Mumps virus vaccine - Sinovac (Dalian) Vaccine Technology
Latest Information Update: 08 Oct 2021
At a glance
- Originator Sinovac (Dalian) Vaccine Technology
- Class Mumps vaccines; Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Mumps
Most Recent Events
- 30 Apr 2016 Sinovac Vaccine Technology completes phase III trials for Mumps (Prevention, In infants) in China (IM, Injection) (NCT05065177)
- 31 Jan 2016 Sinovac Vaccine Technology initiates phase III trials for Mumps (Prevention, In infants) in China (IM, Injection) by January 2016 (NCT05065177)
- 01 Dec 2012 Launched for Mumps (Prevention) in China (IM, Injection)